Spots Global Cancer Trial Database for bronchoalveolar cell lung cancer
Every month we try and update this database with for bronchoalveolar cell lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00553462 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel albu... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction | NCT00009789 | Lung Cancer | accelerated con... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
| Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy | NCT01208064 | Lung Cancer | pazopanib hydro... laboratory biom... pharmacogenomic... pharmacological... quality-of-life... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00265785 | Lung Cancer | pemetrexed | 18 Years - | SWOG Cancer Research Network | |
| Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
| Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00425646 | Lung Cancer | bevacizumab imatinib mesyla... | 18 Years - | University of Washington | |
| Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | NCT00087438 | Lung Cancer | stereotactic bo... | 18 Years - | Radiation Therapy Oncology Group | |
| Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00020007 | Lung Cancer Metastatic Canc... | isolated perfus... paclitaxel hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00117962 | Lung Cancer | cetuximab carboplatin pemetrexed diso... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer | NCT00118144 | Adenocarcinoma ... Bronchoalveolar... Non-small Cell ... Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00293280 | Lung Cancer | lomustine | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC | NCT00354549 | Lung Cancer | bevacizumab + e... gemcitabine hyd... | 18 Years - 120 Years | Swiss Group for Clinical Cancer Research | |
| Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy | NCT00093132 | Carcinoma, Non-... Lung Cancer | Satraplatin | 18 Years - | Agennix | |
| Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer | NCT00955695 | Lung Cancer | erlotinib hydro... gefitinib questionnaire a... quality-of-life... whole-brain rad... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung Cancer | NCT00005630 | Lung Cancer | ras peptide can... sargramostim | 17 Years - | Memorial Sloan Kettering Cancer Center | |
| S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer | NCT00090961 | Lung Cancer Pulmonary Compl... | educational int... supervised exer... | - | SWOG Cancer Research Network | |
| Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status | NCT00986297 | Lung Cancer | hypofractionate... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00293280 | Lung Cancer | lomustine | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer | NCT00369551 | Adenocarcinoma ... Bronchoalveolar... Large Cell Lung... Stage II Non-sm... Stage IIIA Non-... Stage IIIB Non-... | 3-dimensional c... paclitaxel bevacizumab carboplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00425646 | Lung Cancer | bevacizumab imatinib mesyla... | 18 Years - | University of Washington | |
| Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer | NCT00002852 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IB Non-sm... | paclitaxel carboplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer | NCT00087438 | Lung Cancer | stereotactic bo... | 18 Years - | Radiation Therapy Oncology Group | |
| Cetuximab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Unresectable Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | NCT00081302 | Lung Cancer | cetuximab carboplatin paclitaxel radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers | NCT01344824 | Lung Cancer | bevacizumab carboplatin erlotinib hydro... pemetrexed diso... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery | NCT00346320 | Lung Cancer | 3-dimensional c... | 18 Years - | Canadian Cancer Trials Group | |
| Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer | NCT00042835 | Adenocarcinoma ... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | cisplatin etoposide erlotinib hydro... radiation thera... docetaxel paclitaxel carboplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00553462 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel albu... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00234052 | Lung Cancer | bevacizumab carboplatin pemetrexed | 18 Years - 120 Years | Northwestern University | |
| Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00309998 | Lung Cancer | bevacizumab vinorelbine tar... | 70 Years - | University of Rochester | |
| Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | NCT00028938 | Lung Cancer | epoetin alfa carboplatin paclitaxel radiation thera... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer | NCT01107626 | Lung Cancer | Paclitaxel Carboplatin Bevacizumab Pemetrexed Diso... | 18 Years - | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00006378 | Lung Cancer | carboplatin paclitaxel radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00077311 | Anemia Drug/Agent Toxi... Lung Cancer Neutropenia | darbepoetin alf... pegfilgrastim cisplatin docetaxel BNP7787 | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00004139 | Lung Cancer | docetaxel gemcitabine hyd... irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00054392 | Lung Cancer | carboplatin gemcitabine hyd... paclitaxel | 18 Years - | Fox Chase Cancer Center | |
| Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00117962 | Lung Cancer | cetuximab carboplatin pemetrexed diso... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed | NCT00003649 | Lung Cancer | Ad5CMV-p53 gene | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer | NCT00004859 | Lung Cancer | carboplatin paclitaxel thalidomide radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | NCT00077415 | Lung Cancer | gemcitabine hyd... triapine | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer | NCT00776100 | Lung Cancer | clinical observ... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Gefitinib in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | NCT00616499 | Lung Cancer | gefitinib neoadjuvant the... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed | NCT00003649 | Lung Cancer | Ad5CMV-p53 gene | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer | NCT00398385 | Lung Cancer | cisplatin gemcitabine hyd... adjuvant therap... conventional su... neoadjuvant the... | 18 Years - | National Cancer Institute (NCI) | |
| Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00438204 | Lung Cancer | bevacizumab gemcitabine hyd... pemetrexed diso... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC | NCT00354549 | Lung Cancer | bevacizumab + e... gemcitabine hyd... | 18 Years - 120 Years | Swiss Group for Clinical Cancer Research | |
| Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | NCT01958372 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | soy isoflavones cisplatin etoposide pemetrexed diso... radiation thera... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel | NCT00900172 | Lung Cancer | bevacizumab carboplatin paclitaxel gene expression... polymerase chai... polymorphism an... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer | NCT00955695 | Lung Cancer | erlotinib hydro... gefitinib questionnaire a... quality-of-life... whole-brain rad... | 18 Years - | National Cancer Institute (NCI) | |
| Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer | NCT00287963 | Lung Cancer | topotecan hydro... vinorelbine tar... | 18 Years - 120 Years | Medical University of South Carolina | |
| S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer | NCT00090961 | Lung Cancer Pulmonary Compl... | educational int... supervised exer... | - | SWOG Cancer Research Network | |
| Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer | NCT00028938 | Lung Cancer | epoetin alfa carboplatin paclitaxel radiation thera... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer | NCT00499330 | Lung Cancer | lobectomy segmentectomy o... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00040794 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | paclitaxel carboplatin gefitinib radiation thera... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00970684 | Lung Cancer | bevacizumab docetaxel gemcitabine hyd... | 18 Years - 120 Years | Case Comprehensive Cancer Center | |
| S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00368992 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIIB Non-... Stage IV Non-sm... | cetuximab paclitaxel bevacizumab | 18 Years - | National Cancer Institute (NCI) | |
| Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer | NCT00080938 | Lung Cancer Metastatic Canc... | Temozolomide Radiation thera... | 18 Years - | Eastern Cooperative Oncology Group | |
| Specialized Radiation Therapy in Treating Patients With Stage II, Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer and Poor Performance Status | NCT00986297 | Lung Cancer | hypofractionate... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
| 3-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung Cancer | NCT00077415 | Lung Cancer | gemcitabine hyd... triapine | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT01557959 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Non-small Cell ... Recurrent Non-s... Squamous Cell L... Stage IIIB Non-... Stage IV Non-sm... | cisplatin pegfilgrastim erlotinib hydro... laboratory biom... polymorphism an... pharmacogenomic... genetic linkage... docetaxel | 18 Years - | Wake Forest University Health Sciences | |
| S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00368992 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIIB Non-... Stage IV Non-sm... | cetuximab paclitaxel bevacizumab | 18 Years - | National Cancer Institute (NCI) | |
| Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | NCT01958372 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Recurrent Non-s... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | soy isoflavones cisplatin etoposide pemetrexed diso... radiation thera... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy | NCT00365547 | Lung Cancer | bevacizumab topotecan hydro... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT00547443 | Lung Cancer | carboplatin paclitaxel sorafenib tosyl... radiation thera... | 18 Years - 120 Years | University of Texas Southwestern Medical Center | |
| TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer | NCT00036920 | Lung Cancer | canfosfamide hy... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00020709 | Adenocarcinoma ... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IIIA Non-... Stage IIIB Non-... | cisplatin docetaxel etoposide gefitinib radiation thera... placebo | - | National Cancer Institute (NCI) | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
| Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00438204 | Lung Cancer | bevacizumab gemcitabine hyd... pemetrexed diso... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | NCT00979212 | Lung Cancer | panitumumab carboplatin paclitaxel surgery | 18 Years - | Radiation Therapy Oncology Group | |
| Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery | NCT00049543 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IB Non-sm... Stage IIA Non-s... Stage IIB Non-s... Stage IIIA Non-... | gefitinib placebo laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy | NCT01208064 | Lung Cancer | pazopanib hydro... laboratory biom... pharmacogenomic... pharmacological... quality-of-life... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | NCT00004139 | Lung Cancer | docetaxel gemcitabine hyd... irinotecan hydr... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer | NCT00021060 | Adenocarcinoma ... Bronchoalveolar... Large Cell Lung... Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | paclitaxel carboplatin bevacizumab laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00550537 | Lung Cancer | bevacizumab carboplatin erlotinib hydro... paclitaxel gene expression... protein express... proteomic profi... laboratory biom... | 18 Years - 120 Years | Vanderbilt-Ingram Cancer Center | |
| Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer | NCT00006004 | Lung Cancer | carboplatin cisplatin gemcitabine hyd... paclitaxel | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00293280 | Lung Cancer | lomustine | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00754923 | Lung Cancer | sorafenib | 18 Years - | Ohio State University Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
